Importance of the short cytoplasmic domain of the feline immunodeficiency virus transmembrane glycoprotein for fusion activity and envelope glycoprotein incorporation into virions

Virology

Volumn 366, Issue 2, 2007, Pages 405-414

  Celma, Cristina C P ^a   Paladino, Mónica G ^a   González, Silvia A ^a   Affranchino, José L ^a  

^a UNIVERSIDAD DE BELGRANO   (Argentina)

Author keywords

Envelope cytoplasmic domain; Envelope glycoprotein; Feline immunodeficiency virus; Fusogenic activity; Transmembrane glycoprotein

Indexed keywords

AMINO ACID; ENVELOPE PROTEIN; MEMBRANE PROTEIN; MUTANT PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; BIOLOGICAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CELL FUSION; CELL SURFACE; CYTOPLASM; FELINE IMMUNODEFICIENCY VIRUS; GENE DELETION; MODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; VIRION; VIRUS EXPRESSION; WILD TYPE;

ANIMALS; CAPSID; CATS; CELL FUSION; CELL LINE; GLYCOPROTEINS; IMMUNODEFICIENCY VIRUS, FELINE; PROTEIN STRUCTURE, TERTIARY; SEQUENCE DELETION; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS;

EID: 34548589038     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.05.019     Document Type: Article

References (53)

1. Affranchino J.L., and González S.A. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions. Virology 347 (2006) 217-225
2. Berlioz-Torrent C., Shacklett B.L., Erdtmann L., Delamarre L., Bouchaert I., Sonigo P., Dokhélar M.C., and Bénarous R. Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins. J. Virol. 73 (1999) 1350-1361
3. Brown W.C., Bissey L., Logan K.S., Pedersen N.C., Elder J.H., and Collisson E.W. Feline immunodeficiency virus infects both CD4+ and CD8+ T lymphocytes. J. Virol. 65 (1991) 3359-3364
4. Brunner D., and Pedersen N.C. Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus. J. Virol. 63 (1989) 5483-5488
5. Celma C.C.P., Manrique J.M., Affranchino J.L., Hunter E., and González S.A. Domains in the simian immunodeficiency virus gp41 cytoplasmic tail required for envelope incorporation into particles. Virology 283 (2001) 253-261
6. Chakrabarti L., Emerman M., Tiollais P., and Sonigo P. The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity. J. Virol. 63 (1989) 4395-4403
7. Dean G.A., Himathongkham S., and Sparger E.E. Differential cell tropism of feline immunodeficiency virus molecular clones in vivo. J. Virol. 73 (1999) 2596-2603
8. de Parseval A., and Elder J.H. Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor. J. Virol. 75 (2001) 4528-4539
9. de Parseval A., Chatterji U., Sun P., and Elder J.H. Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 13044-13049
10. Dow S.W., Mathiason C.K., and Hoover E.A. In vivo monocyte tropism of pathogenic feline immunodeficiency viruses. J. Virol. 73 (1999) 6852-6861
11. Dubay J.W., Roberts S.J., Hahn B.H., and Hunter E. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J. Virol. 66 (1992) 6616-6625
12. Earl P.L., Koenig S., and Moss B. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J. Virol. 65 (1991) 31-41
13. Edwards T.G., Wyss S., Reeves J.D., Zolla-Pazner S., Hoxie J.A., Doms R.W., and Baribaud F. Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 76 (2002) 2683-2691
14. English R.V., Johnson C.M., Gebhard D.H., and Tompkins M.B. In vivo lymphocyte tropism of feline immunodeficiency virus. J. Virol. 67 (1993) 5175-5186
15. Freed E.O., and Martin M.A. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69 (1995) 1984-1989
16. Freed E.O., and Martin M.A. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70 (1996) 341-351
17. Gabuzda D., Lever A., Terwilliger E., and Sodroski J. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 66 (1992) 3306-3315
18. Garg H., Fuller F.J., and Tompkins W.A.F. Mechanism of feline immunodeficiency virus envelope glycoprotein-mediated fusion. Virology 321 (2004) 274-286
19. Giannecchini S., Bonci F., Pistello M., Matteucci D., Sichi O., Rovero P., and Bendinelli M. The membrane-proximal tryptophan-rich region in the transmembrane glycoprotein ectodomain of feline immunodeficiency virus is important for cell entry. Virology 320 (2004) 156-166
20. González S.A., Burny A., and Affranchino J.L. Identification of domains in the simian immunodeficiency virus matrix protein essential for assembly and envelope glycoprotein incorporation. J. Virol. 70 (1996) 6384-6389
21. Hosie M.J., Willett B.J., Dunsford T.H., Jarrett O., and Neil J.C. A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor. J. Virol. 67 (1993) 1667-1671
22. Hosie M.J., Klein D., Binley J.M., Dunsford T.H., Jarrett O., Neil J.C., Knapp E., Giannecchini S., Matteucci D., Bendinelli M., Hoxie J.A., and Willett B.J. Vaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of Env. J. Virol. 79 (2005) 1954-1957
23. Hunter E. gp41, a multifunctional protein involved in HIV entry and pathogenesis. In: Korber B., Hahn B., Foley B., Mellors J.W., Leitner T., Myers G., McCutchan F., and Kuiken C.L. (Eds). Human Retroviruses and AIDS 1997: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences (1997), Los Alamos Natl. Lab, Los Alamos, NM Iii-55-iii-73
24. Hunter E., and Swanstrom R. Retrovirus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 157 (1990) 187-253
25. Johnston P.B., Dubay J.W., and Hunter E. Truncations of the simian immunodeficiency virus transmembrane protein confer expanded host range by removing a block to virus entry into cells. J. Virol. 67 (1993) 3077-3086
26. Kalia V., Sarkar S., Gupta P., and Montelaro R.C. Rational site-directed mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate common functions in cell-cell fusion but distinct roles in virus envelope incorporation. J. Virol. 77 (2003) 3634-3646
27. Kimpton J., and Emerman E. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66 (1992) 2232-2239
28. Kodama T., Wooley D.P., Naidu Y.M., Kestler H.W., Daniel M.D., Li Y., and Desrosiers R.C. Significance of premature stop codons in env of simian immunodeficiency virus. J. Virol. 63 (1989) 4709-4714
29. LaBranche C.C., Sauter M.M., Haggarty B.S., Vance P.J., Romano J., Hart T.K., Bugelski P.J., Marsh M., and Hoxie J.A. A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells. J. Virol. 69 (1995) 5217-5227
30. Mammano F., Kondo E., Sodroski J., Bukovsky A., and Göttlinger H.G. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 69 (1995) 3824-3830
31. Manrique J.M., Celma C.C.P., Affranchino J.L., Hunter E., and González S.A. Small variations in the length of the cytoplasmic domain of the simian immunodeficiency virus transmembrane protein drastically affect envelope incorporation and virus entry. AIDS Res. Hum. Retroviruses 17 (2001) 1615-1624
32. Manrique J.M., Celma C.C.P., Hunter E., Affranchino J.L., and González S.A. Positive and negative modulation of virus infectivity and envelope glycoprotein incorporation into virions by amino acid substitutions at the N-terminus of the simian immunodeficiency virus matrix protein. J. Virol. 77 (2003) 10881-10888
33. Manrique M.L., Rauddi M.L., González S.A., and Affranchino J.L. Functional domains in the feline immunodeficiency virus nucleocapsid protein. Virology 327 (2004) 83-92
34. Murakami T., and Freed E.O. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and α-helix 2 of the gp41 cytoplasmic tail. J. Virol. 74 (2000) 3548-3554
35. Olmsted R.A., Barnes A.K., Yamamoto J.K., Hirsch V.M., Purcell R.H., and Johnson P.R. Molecular cloning of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86 (1989) 2448-2452
36. Pancino G., Camoin L., and Sonigo P. Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein. J. Virol. 69 (1995) 2110-2118
37. Pedersen N.C., Ho E.W., Brown M.L., and Yamamoto J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235 (1987) 790-793
38. Phillips T.R., Lamont C., Konings D.A., Shacklett B.L., Hamson C.A., Luciw P.A., and Elder J.H. Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J. Virol. 66 (1992) 5464-5471
39. Piller S.C., Dubay J.W., Derdeyn C.A., and Hunter E. Mutational analysis of conserved domains within the cytoplasmic tail of gp41 from human immunodeficiency virus type 1: effects on glycoprotein incorporation and infectivity. J. Virol. 74 (2000) 11717-11723
40. Poeschla E.M., and Looney D.J. CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells. J. Virol. 72 (1998) 6858-6866
41. Rice N.R., Henderson L.E., Sowder R.C., Copeland T.D., Oroszlan S., and Edwards J.F. Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus. J. Virol. 64 (1990) 3770-3778
42. Richardson J., Pancino G., Merat R., Leste-Lasserre T., Moraillon A., Schneider-Mergener J., Alizon M., Sonigo P., and Heveker N. Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus. J. Virol. 73 (1999) 3661-3671
43. Ritter Jr. G.D., Mulligan M.J., Lydy S.L., and Compans R.W. Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain. Virology 197 (1993) 255-264
44. Saltarelli M., Querat G., Konings D.A., Vigne R., and Clements J.E. Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus. Virology 179 (1990) 347-364
45. Shimojima M., Miyasawa T., Ikeda Y., McMonagle E.L., Haining H., Akashi H., Takeuchi Y., Hosie M.J., and Willett B.J. Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 303 (2004) 1192-1195
46. Sonigo P., Alizon M., Staskus K., Klatzmann D., Cole S., Danos O., Retzel E., Tiollais P., Haase A., and Wain-Hobson S. Nucleotide sequence of the visna lentivirus: relationship with the AIDS virus. Cell 42 (1985) 369-382
47. Spies C.P., and Compans R.W. Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein. Virology 203 (1994) 8-19
48. Verschoor E.J., Hulskotte E.G.J., Ederveen J., Koolen M.J.M., Horzinek M.C., and Rottier P.J.M. Post-translational processing of the feline immunodeficiency virus envelope precursor protein. Virology 193 (1993) 433-438
49. Willett B.J., Picard L., Hosie M.J., Turner J.D., Adema K., and Clapham P.R. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol. 71 (1997) 6407-6415
50. Gag in immature human immunodeficiency virus type 1 particles. J. Virol. 74 (2000) 9381-9387
51. Wyss S., Dimitrov A.S., Baribaud F., Edwards T.G., Blumenthal R., and Hoxie J.A. Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail. J. Virol. 79 (2005) 12231-12241
52. Yu X., Yuan X., McLane M.F., Lee T.-H., and Essex M. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. J. Virol. 67 (1993) 213-221
53. Zingler K., and Littman D.R. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases Env incorporation into particles and fusogenicity and infectivity. J. Virol. 67 (1993) 2824-2831